Core Viewpoint - The company *ST Chuntian is facing scrutiny from the Shanghai Stock Exchange regarding the authenticity of its revenue, compliance of revenue deductions, and risks of fund occupation, which are critical for its survival in the capital market [1][9]. Revenue Authenticity Concerns - *ST Chuntian's business includes two main categories: liquor and cordyceps, with its core product, Tinghua liquor, suffering a significant decline in reputation and sales after being exposed by CCTV two years ago [2][11]. - The company has reported continuous losses over the past five years, with revenue fluctuating between 120 million and 270 million yuan. The 2024 financial report triggered a delisting risk warning due to negative net profit and insufficient revenue [2][11]. - The 2025 performance is crucial, coinciding with the strictest "alcohol ban" in the liquor industry, which is expected to further impact *ST Chuntian negatively [2][11]. Financial Forecast and Risks - On January 29, the company announced a revenue forecast for the previous year between 343 million and 371 million yuan, with a net loss estimated between 44 million and 59.5 million yuan. However, this forecast has not been audited, leaving the company at risk of delisting [2][11]. - The annual auditor's report indicated uncertainty regarding the authenticity of the revenue exceeding 300 million yuan, and if prepaid investment funds cannot be recovered, the auditor may issue a disclaimer of opinion [2][11]. Regulatory Scrutiny - On February 6, the Shanghai Stock Exchange issued a letter addressing three main issues: the authenticity of revenue, compliance of revenue deductions, and risks of fund occupation, particularly questioning the significant revenue growth in the fourth quarter [5][14]. - The company has a history of being penalized for non-compliance in financial disclosures, including instances where reported revenues did not meet actual figures, leading to public reprimands for its executives [7][16]. Previous Violations and Concerns - *ST Chuntian has faced multiple accusations of inflated performance figures, with auditors questioning the commercial rationale behind significant revenue increases, particularly in December of the previous year [8][17]. - Regulatory bodies have mandated corrections for undisclosed related party transactions, further complicating the company's compliance standing [8][17].
听花酒母公司*ST春天延期回复监管函,保壳之战生悬念